A generic form of mifepristone, approved by the FDA, is now accessible to abortion care providers and their patients in the United States. GenBioPro's mifepristone represents the inaugural FDA-approved generic medication for medical abortion in the US. The FDA has confirmed that the generic mifepristone is comparable to the branded drug in terms of efficacy, quality, and safety. Medical facilities can now take advantage of consistent product availability, competitive pricing, convenient provider-specific packaging, and effortless ordering of the 200mg generic mifepristone from GenBioPro.
Genbiopro
Headquarters
United States of America